002581 *ST未名醫藥
按盤價 
5.340 -0.120 (-2.198%)
5.340 -0.120 (-2.198%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -5.279 | -6.176 | -6.879 | -14.929 | -0.614 |
| 總資產報酬率 ROA (%) | -4.531 | -5.329 | -6.058 | -12.770 | -0.521 |
| 投入資產回報率 ROIC (%) | -5.054 | -5.887 | -6.645 | -14.132 | -0.566 | 邊際利潤分析 |
| 銷售毛利率 (%) | 12.929 | 52.842 | 79.785 | 80.596 | 78.657 |
| 營業利潤率 (%) | -109.946 | -65.134 | -30.930 | -68.255 | 9.430 |
| 息稅前利潤/營業總收入 (%) | -112.604 | -64.965 | -41.749 | -71.178 | 5.609 |
| 淨利潤/營業總收入 (%) | -111.730 | -58.525 | -39.632 | -74.952 | -0.240 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.802 | 83.278 | 52.375 | 57.758 | -1,464.805 |
| 價值變動淨收益/利潤總額(%) | 5.212 | -9.585 | -42.915 | -55.126 | 1,708.919 |
| 營業外收支淨額/利潤總額(%) | 2.534 | -1.972 | 23.741 | 6.352 | -164.616 | 償債能力分析 |
| 流動比率 (X) | 4.643 | 3.299 | 9.043 | 3.718 | 1.423 |
| 速動比率 (X) | 3.650 | 2.810 | 8.079 | 3.079 | 1.203 |
| 資產負債率 (%) | 8.608 | 10.238 | 7.906 | 6.992 | 13.571 |
| 帶息債務/全部投入資本 (%) | 2.879 | 3.264 | 0.391 | 0.566 | 7.092 |
| 股東權益/帶息債務 (%) | 3,331.774 | 2,927.526 | 24,345.700 | 17,332.748 | 1,296.269 |
| 股東權益/負債合計 (%) | 1,007.824 | 829.842 | 1,108.008 | 1,265.802 | 612.512 |
| 利息保障倍數 (X) | -561.843 | 59.576 | 35.077 | -41.719 | 2.742 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 448.523 | 222.388 | 103.234 | 125.947 | 211.052 |
| 存貨周轉天數 (天) | 250.373 | 240.136 | 407.533 | 356.911 | 340.998 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 11/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
